AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Medexus Pharmaceuticals Inc.

CAD 5.01 +$1.92 (+62.14%)
TSX · 14 Sep 2026 20:00 UTC
Previous Close
CAD 5.08
Day Range
CAD 4.98CAD 5.06
Year Range
CAD 2.51CAD 5.5
Market Cap
158.62M
AVG Volume
45.95K
Trailing/Forward PE
-47.23/29.23
PEG ratio
-0.21
Dividend Yield
-
Next Earnings Date
2026-11-11
Primary Exchange
Toronto Stock ExchangeCA
Revenue (USD)
010M20M30M24 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q427 Q1
MDP.TO Revenue (USD) by quarter
PeriodRevenue (USD)
27 Q128.59M
26 Q424.65M
26 Q325.32M
26 Q224.74M
26 Q124.61M
25 Q424.75M
25 Q329.99M
25 Q226.3M
25 Q127.28M
24 Q425.96M
Net Income (USD)
-4M-2M02M24 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q427 Q1
MDP.TO Net Income (USD) by quarter
PeriodNet Income (USD)
27 Q1547.66K
26 Q4-2.67M
26 Q380K
26 Q2-315K
26 Q1516K
25 Q4-553K
25 Q3733K
25 Q2110K
25 Q11.96M
24 Q4762K
Operating Income (USD)
-2M02M4M24 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q427 Q1
MDP.TO Operating Income (USD) by quarter
PeriodOperating Income (USD)
27 Q12.13M
26 Q41.66M
26 Q31.7M
26 Q21.38M
26 Q1850K
25 Q4-1.17M
25 Q33.78M
25 Q21.64M
25 Q13.97M
24 Q4832K
EBITDA (USD)
02M4M6M24 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q427 Q1
MDP.TO EBITDA (USD) by quarter
PeriodEBITDA (USD)
27 Q14.56M
26 Q4475K
26 Q34.16M
26 Q23.51M
26 Q14.45M
25 Q43.68M
25 Q34.63M
25 Q23.16M
25 Q15.34M
24 Q45.35M
Cash Flows (USD)
-15M-10M-5M05M10M24 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q427 Q1
MDP.TO Cash Flows (USD) by quarter
PeriodCash Flows (USD)
27 Q1-1.14M
26 Q4-11.22M
26 Q37.81M
26 Q23.33M
26 Q13.79M
25 Q42.22M
25 Q36.61M
25 Q24.32M
25 Q18.16M
24 Q41.39M
EPS (USD)
-0.1-0.0500.050.124 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q427 Q1
MDP.TO EPS (USD) by quarter
PeriodEPS (USD)
27 Q10.02
26 Q4-0.09
26 Q30
26 Q2-0.01
26 Q10.02
25 Q4-0.02
25 Q30.03
25 Q20
25 Q10.08
24 Q40.04
Expenses (USD)
010M20M30MR&DSG&ACapex24 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q427 Q1
MDP.TO Expenses (USD) by quarter
PeriodExpenses (USD)
27 Q112.16M
26 Q426.54M
26 Q311.85M
26 Q212.07M
26 Q112.98M
25 Q412.7M
25 Q311.45M
25 Q212.51M
25 Q110.48M
24 Q410.61M
Cash & Debt (USD)
020M40M60MCashLong Term DebtShort Term Debt24 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q427 Q1
MDP.TO Cash & Debt (USD) by quarter
PeriodCash & Debt (USD)
27 Q15.34M
26 Q46.52M
26 Q314.97M
26 Q29.38M
26 Q19.33M
25 Q423.97M
25 Q38.44M
25 Q26.97M
25 Q18.45M
24 Q45.25M
Debt ratios
012324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q427 Q1
MDP.TO Debt ratios by quarter
PeriodDebt ratios
27 Q11.64
26 Q41.25
26 Q30.66
26 Q20.72
26 Q10.79
25 Q40.79
25 Q31.7
25 Q22.1
25 Q11.98
24 Q42.16
Margins
0%20%40%60%24 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q427 Q1
MDP.TO Margins by quarter
PeriodMargins
27 Q155.63%
26 Q453.84%
26 Q353.62%
26 Q255.72%
26 Q155.96%
25 Q450.22%
25 Q350.65%
25 Q253.7%
25 Q154.37%
24 Q451.25%
Return on Capital
-10%-5%0%5%10%24 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q427 Q1
MDP.TO Return on Capital by quarter
PeriodReturn on Capital
27 Q11.14%
26 Q4-5.46%
26 Q30.15%
26 Q2-0.6%
26 Q10.97%
25 Q4-1.06%
25 Q32.21%
25 Q20.34%
25 Q16.01%
24 Q42.51%
Shares Outstanding
010M20M30M40M24 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q427 Q1
MDP.TO Shares Outstanding by quarter
PeriodShares Outstanding
27 Q131.83M
26 Q432.03M
26 Q332.43M
26 Q232.29M
26 Q132.26M
25 Q425.82M
25 Q324.68M
25 Q224.46M
25 Q124.46M
24 Q424.46M
Book Value Per Share (USD)
012324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q427 Q1
MDP.TO Book Value Per Share (USD) by quarter
PeriodBook Value Per Share (USD)
27 Q11.51
26 Q41.53
26 Q31.61
26 Q21.62
26 Q11.64
25 Q42.02
25 Q31.34
25 Q21.34
25 Q11.33
24 Q41.24
Total Assets (USD)
050M100M150M200M24 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q427 Q1
MDP.TO Total Assets (USD) by quarter
PeriodTotal Assets (USD)
27 Q1141.86M
26 Q4147.28M
26 Q3154.98M
26 Q2149.44M
26 Q1153.79M
25 Q4171.84M
25 Q3145.98M
25 Q2145.37M
25 Q1147.26M
24 Q4155.73M
PE Ratio
050100150200med 24.57Apr 24Oct 24Jan 25May 25Aug 25Dec 25Mar 26
MDP.TO PE Ratio by quarter
PeriodPE Ratio
Mar 26187.92
Mar 26188.41
Mar 26193.95
Mar 26193.75
Feb 26178.97
Feb 26179.12
Feb 26178.04
Feb 26176.06
Jan 26176.14
Jan 26177.58
Jan 26171.16
Jan 26175.46
Jan 26190.76
Dec 2581.1
Dec 2577.17
Dec 2575.86
Dec 2578.8
Nov 2579.64
Nov 2576.66
Nov 2577.09
Nov 2576.37
Oct 2580.04
Oct 2582.09
Oct 2577.09
Oct 2577.5
Oct 2582.09
Sep 2522.84
Sep 2525.28
Sep 2525.15
Sep 2525.6
Aug 2525.51
Aug 2523.86
Aug 2524.54
Aug 2521.81
Aug 2522.17
Jul 2523.83
Jul 2523.54
Jul 2524.61
Jul 2526.29
Jun 2515.95
Jun 2516.24
Jun 2514.95
Jun 2514.37
May 2515.53
May 2513.88
May 2513.34
May 2514.52
May 2513.84
Apr 2513.51
Apr 2512.77
Apr 2510.59
Apr 2510.47
Mar 2517.88
Mar 2520.06
Mar 2518.84
Mar 2519.59
Feb 2520.79
Feb 2521.52
Feb 2523.23
Feb 2523.95
Jan 2528.26
Jan 2536.57
Jan 2531.66
Jan 2529.87
Jan 2525.24
Dec 2451.31
Dec 2443.96
Dec 2445.66
Dec 2445.75
Nov 2444.01
Nov 2439.28
Nov 2433.72
Nov 2434.96
Nov 2439.04
Oct 2441.29
Oct 2440.92
Oct 2442.33
Oct 2444.24
Jun 245.47
Jun 245.08
Jun 244.64
Jun 245.32
May 244.89
May 244.91
May 244.83
May 244.78
May 245.38
Apr 245.78
Apr 244.94
Apr 244.72
Apr 244.9
Mar 244.95
Mar 244.78
Mar 244.74
Mar 245.25
Mar 245.59
Feb 245.24
Feb 245.41
Feb 245.79
Feb 247.58
Free Cash Flow Yield
0%20%40%60%80%med 27.47%Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
MDP.TO Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Sep 263.17%
Sep 263.18%
Aug 263.19%
Aug 263.11%
Aug 263.02%
Aug 263.2%
Jul 263.24%
Jul 263.25%
Jul 263.21%
Jul 263.17%
Jul 263.21%
Jun 2617.87%
Jun 2617.82%
Jun 2618.46%
Jun 2618.86%
May 2618.8%
May 2618.32%
May 2618.14%
May 2617.95%
May 2617.93%
Apr 2618.21%
Apr 2618.24%
Apr 2618.58%
Apr 2621.04%
Mar 2622.28%
Mar 2622.22%
Mar 2621.59%
Mar 2621.61%
Feb 2623.4%
Feb 2623.38%
Feb 2623.52%
Feb 2623.78%
Jan 2623.77%
Jan 2623.58%
Jan 2624.46%
Jan 2623.86%
Jan 2621.95%
Dec 2525.92%
Dec 2527.24%
Dec 2527.71%
Dec 2526.67%
Nov 2526.39%
Nov 2527.42%
Nov 2527.27%
Nov 2527.52%
Oct 2526.26%
Oct 2525.6%
Oct 2527.26%
Oct 2527.12%
Oct 2525.6%
Sep 2541.52%
Sep 2537.5%
Sep 2537.7%
Sep 2537.04%
Aug 2537.17%
Aug 2539.74%
Aug 2538.64%
Aug 2543.48%
Aug 2542.77%
Jul 2539.8%
Jul 2540.28%
Jul 2538.54%
Jul 2536.07%
Jun 2536.03%
Jun 2535.38%
Jun 2538.45%
Jun 2539.99%
May 2537%
May 2541.42%
May 2543.08%
May 2539.58%
May 2541.52%
Apr 2542.55%
Apr 2545.01%
Apr 2554.26%
Apr 2554.9%
Mar 2547.3%
Mar 2542.16%
Mar 2544.87%
Mar 2543.15%
Feb 2540.67%
Feb 2539.29%
Feb 2536.4%
Feb 2535.3%
Jan 2529.92%
Jan 2523.12%
Jan 2526.71%
Jan 2528.3%
Jan 2533.5%
Dec 2440.02%
Dec 2446.7%
Dec 2444.97%
Dec 2444.88%
Nov 2446.66%
Nov 2452.27%
Nov 2460.89%
Nov 2458.72%
Nov 2452.6%
Oct 2449.72%
Oct 2450.18%
Price to Sales
0.250.50.7511.25med 0.59Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
MDP.TO Price to Sales by quarter
PeriodPrice to Sales
Sep 261.18
Sep 261.18
Aug 261.17
Aug 261.2
Aug 261.24
Aug 261.17
Jul 261.16
Jul 261.15
Jul 261.17
Jul 261.18
Jul 261.17
Jun 260.97
Jun 260.97
Jun 260.93
Jun 260.91
May 260.92
May 260.94
May 260.95
May 260.96
May 260.96
Apr 260.95
Apr 260.95
Apr 260.93
Apr 260.82
Mar 260.69
Mar 260.69
Mar 260.71
Mar 260.71
Feb 260.65
Feb 260.66
Feb 260.65
Feb 260.64
Jan 260.64
Jan 260.65
Jan 260.63
Jan 260.64
Jan 260.7
Dec 250.62
Dec 250.59
Dec 250.58
Dec 250.6
Nov 250.61
Nov 250.58
Nov 250.59
Nov 250.58
Oct 250.61
Oct 250.63
Oct 250.59
Oct 250.59
Oct 250.63
Sep 250.47
Sep 250.52
Sep 250.52
Sep 250.53
Aug 250.53
Aug 250.49
Aug 250.51
Aug 250.45
Aug 250.46
Jul 250.49
Jul 250.49
Jul 250.51
Jul 250.55
Jun 250.52
Jun 250.53
Jun 250.49
Jun 250.47
May 250.51
May 250.45
May 250.43
May 250.47
May 250.45
Apr 250.44
Apr 250.42
Apr 250.34
Apr 250.34
Mar 250.39
Mar 250.44
Mar 250.41
Mar 250.43
Feb 250.46
Feb 250.47
Feb 250.51
Feb 250.52
Jan 250.62
Jan 250.8
Jan 250.69
Jan 250.65
Jan 250.55
Dec 240.52
Dec 240.44
Dec 240.46
Dec 240.46
Nov 240.44
Nov 240.39
Nov 240.34
Nov 240.35
Nov 240.39
Oct 240.41
Oct 240.41
EV/EBITDA
24681012med 4.83Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
MDP.TO EV/EBITDA by quarter
PeriodEV/EBITDA
Sep 2610.57
Sep 2610.55
Aug 2610.51
Aug 2610.75
Aug 2611.04
Aug 2610.48
Jul 2610.36
Jul 2610.35
Jul 2610.47
Jul 2610.58
Jul 2610.45
Jun 266.73
Jun 266.75
Jun 266.54
Jun 266.42
May 266.43
May 266.59
May 266.65
May 266.71
May 266.72
Apr 266.62
Apr 266.61
Apr 266.5
Apr 265.82
Mar 265.12
Mar 265.13
Mar 265.26
Mar 265.26
Feb 264.91
Feb 264.91
Feb 264.89
Feb 264.84
Jan 264.84
Jan 264.88
Jan 264.73
Jan 264.83
Jan 265.19
Dec 254.9
Dec 254.7
Dec 254.63
Dec 254.78
Nov 254.82
Nov 254.67
Nov 254.69
Nov 254.66
Oct 254.84
Oct 254.95
Oct 254.69
Oct 254.71
Oct 254.95
Sep 253.84
Sep 254.16
Sep 254.15
Sep 254.21
Aug 254.2
Aug 253.97
Aug 254.07
Aug 253.7
Aug 253.75
Jul 253.97
Jul 253.93
Jul 254.07
Jul 254.3
Jun 254.78
Jun 254.83
Jun 254.58
Jun 254.47
May 254.7
May 254.38
May 254.28
May 254.5
May 254.37
Apr 254.31
Apr 254.17
Apr 253.75
Apr 253.72
Mar 254.49
Mar 254.78
Mar 254.62
Mar 254.72
Feb 254.88
Feb 254.98
Feb 255.21
Feb 255.3
Jan 255.88
Jan 256.99
Jan 256.33
Jan 256.09
Jan 255.48
Dec 244.86
Dec 244.45
Dec 244.55
Dec 244.55
Nov 244.45
Nov 244.19
Nov 243.88
Nov 243.94
Nov 244.17
Oct 244.3
Oct 244.28
Price/Operating Cashflow
02468med 3.12Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
MDP.TO Price/Operating Cashflow by quarter
PeriodPrice/Operating Cashflow
Sep 266.22
Sep 266.21
Aug 266.18
Aug 266.34
Aug 266.53
Aug 266.16
Jul 266.08
Jul 266.07
Jul 266.15
Jul 266.22
Jul 266.14
Jun 265.53
Jun 265.54
Jun 265.35
Jun 265.24
May 265.26
May 265.39
May 265.45
May 265.5
May 265.51
Apr 265.43
Apr 265.42
Apr 265.32
Apr 264.7
Mar 264.41
Mar 264.42
Mar 264.55
Mar 264.54
Feb 264.2
Feb 264.2
Feb 264.18
Feb 264.13
Jan 264.13
Jan 264.17
Jan 264.01
Jan 264.12
Jan 264.47
Dec 253.31
Dec 253.15
Dec 253.09
Dec 253.21
Nov 253.25
Nov 253.13
Nov 253.14
Nov 253.12
Oct 253.26
Oct 253.35
Oct 253.14
Oct 253.16
Oct 253.35
Sep 252.14
Sep 252.36
Sep 252.35
Sep 252.39
Aug 252.39
Aug 252.23
Aug 252.29
Aug 252.04
Aug 252.07
Jul 252.23
Jul 252.2
Jul 252.3
Jul 252.46
Jun 252.43
Jun 252.48
Jun 252.28
Jun 252.19
May 252.37
May 252.12
May 252.03
May 252.21
May 252.11
Apr 252.06
Apr 251.95
Apr 251.62
Apr 251.6
Mar 251.85
Mar 252.07
Mar 251.95
Mar 252.03
Feb 252.15
Feb 252.23
Feb 252.4
Feb 252.48
Jan 252.92
Jan 253.78
Jan 253.27
Jan 253.09
Jan 252.61
Dec 242.47
Dec 242.12
Dec 242.2
Dec 242.2
Nov 242.12
Nov 241.89
Nov 241.62
Nov 241.68
Nov 241.88
Oct 241.99
Oct 241.97
Price to Book
0.511.522.53med 1.41Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
MDP.TO Price to Book by quarter
PeriodPrice to Book
Sep 262.39
Sep 262.39
Aug 262.38
Aug 262.44
Aug 262.52
Aug 262.37
Jul 262.34
Jul 262.34
Jul 262.37
Jul 262.4
Jul 262.37
Jun 261.84
Jun 261.84
Jun 261.78
Jun 261.74
May 261.75
May 261.79
May 261.81
May 261.83
May 261.83
Apr 261.8
Apr 261.8
Apr 261.77
Apr 261.56
Mar 261.37
Mar 261.37
Mar 261.41
Mar 261.41
Feb 261.3
Feb 261.3
Feb 261.29
Feb 261.28
Jan 261.28
Jan 261.29
Jan 261.24
Jan 261.28
Jan 261.39
Dec 251.23
Dec 251.17
Dec 251.15
Dec 251.2
Nov 251.21
Nov 251.17
Nov 251.17
Nov 251.16
Oct 251.22
Oct 251.25
Oct 251.17
Oct 251.18
Oct 251.25
Sep 250.98
Sep 251.09
Sep 251.08
Sep 251.1
Aug 251.1
Aug 251.03
Aug 251.06
Aug 250.94
Aug 250.96
Jul 251.03
Jul 251.01
Jul 251.06
Jul 251.13
Jun 251.72
Jun 251.75
Jun 251.61
Jun 251.55
May 251.67
May 251.49
May 251.44
May 251.56
May 251.49
Apr 251.45
Apr 251.37
Apr 251.14
Apr 251.13
Mar 251.25
Mar 251.41
Mar 251.32
Mar 251.37
Feb 251.46
Feb 251.51
Feb 251.63
Feb 251.68
Jan 251.98
Jan 252.56
Jan 252.22
Jan 252.09
Jan 251.77
Dec 241.72
Dec 241.47
Dec 241.53
Dec 241.53
Nov 241.47
Nov 241.32
Nov 241.13
Nov 241.17
Nov 241.31
Oct 241.38
Oct 241.37
Medexus Pharmaceuticals Inc.
MDP.TO
Stockpicker

Video analysis: MDP.TO

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.